Despite several decades of study, the mechanisms of neural circuit disturbances leading to major psychiatric symptoms remain poorly understood. Nevertheless, deciphering the circuit basis of neuropsychiatric disorders holds great potential for unifying the diverse manifestations of synaptic pathophysiology thought to lie at the root of these conditions. Moreover, distilling the polygenic basis for major psychiatric illnesses as interactions of risk alleles that alter molecular pathways important for neuronal connectivity may explain how certain risk alleles can contribute to multiple disorders [1] [2] [3] [4] [5] .
a r t I C l e S Despite several decades of study, the mechanisms of neural circuit disturbances leading to major psychiatric symptoms remain poorly understood. Nevertheless, deciphering the circuit basis of neuropsychiatric disorders holds great potential for unifying the diverse manifestations of synaptic pathophysiology thought to lie at the root of these conditions. Moreover, distilling the polygenic basis for major psychiatric illnesses as interactions of risk alleles that alter molecular pathways important for neuronal connectivity may explain how certain risk alleles can contribute to multiple disorders [1] [2] [3] [4] [5] .
This conceptual framing of psychiatric disorders as circuit and pathway disruptions 6 has stimulated recent analyses of genetic risk data sets for synaptic regulatory pathways that are over-represented among neuropsychiatric risk alleles. One molecular pathway notably highlighted by this approach is the regulation of the synaptic actin cytoskeleton 1, [7] [8] [9] . Indeed, neuropsychiatric risk genes such as SHANK3, GIT1, DISC1, SRGAP3, OPHN1, LIMK1, NRG1, CYFIP1, SYNGAP1, KALRN and CNKSR2 functionally orchestrate the upstream regulation of signaling events that modulate actin cytoskeletal dynamics in dendritic spines [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . Dendritic spines serve as the sites for most excitatory synaptic transmission in the brain; morphological abnormalities of these structures are implicated in multiple psychiatric and neurodevelopmental disorders 22, 23 . Actin dynamics in spines is intimately associated with spine morphogenesis and the efficacy of synaptic transmission 24, 25 . However, it remains unclear how disruptions of the synaptic actin cytoskeletal pathway directly relate to the synaptic pathophysiologies that result in neural circuit disturbances.
Recently, we analyzed the actin signaling pathway in mice, testing whether the functional loss of the Arp2/3 complex in excitatory neurons of the cerebral cortex can model synaptic and behavioral phenotypes congruent to endophenotypes relevant to psychiatric disorders 25 . The Arp2/3 complex directly stimulates actin polymerization in spines downstream of synaptic activation of the small GTPase Rac and is composed of seven subunits 24 , including the critical ArpC3 subunit that we conditionally targeted with a loxP-flanked (f) allele (Arpc3 f/f :Camk2a-Cre, hereafter referred to as Arp2/3 mutant mice). Inhibition of this molecular pathway in cortical pyramidal neurons by deletion of Arpc3 resulted in a gradual loss of dendritic spines and in the progressive onset of behavioral abnormalities, including cognitive deficiencies, sociability deficits, reduced sensorimotor gating and locomotor hyperactivity 25 .
We report here the identification and analysis of a long-range neural circuit disturbance in the Arp2/3 mutant mice. We demonstrate that loss of Arp2/3 activity, which induces spine loss and abnormal synaptic contacts, leads to an autonomous enhancement of excitation of pyramidal cells in the frontal cortex. This abnormality results in elevated striatal dopamine (DA) and antipsychotic-responsive psychomotor disturbances, via a long-range projection to midbrain tyrosine hydroxylase (TH)-positive neurons. Together these findings demonstrate that diverse pathologies (cortical spine pruning, cortical Psychiatric and neurodevelopmental disorders may arise from anomalies in long-range neuronal connectivity downstream of pathologies in dendritic spines. However, the mechanisms that may link spine pathology to circuit abnormalities relevant to atypical behavior remain unknown. Using a mouse model to conditionally disrupt a critical regulator of the dendritic spine cytoskeleton, the actin-related protein 2/3 complex (Arp2/3), we report here a molecular mechanism that unexpectedly reveals the inter-relationship of progressive spine pruning, elevated frontal cortical excitation of pyramidal neurons and striatal hyperdopaminergia in a cortical-to-midbrain circuit abnormality. The main symptomatic manifestations of this circuit abnormality are psychomotor agitation and stereotypical behaviors, which are relieved by antipsychotics. Moreover, this antipsychoticresponsive locomotion can be mimicked in wild-type mice by optogenetic activation of this circuit. Collectively these results reveal molecular and neural-circuit mechanisms, illustrating how diverse pathologies may converge to drive behaviors relevant to psychiatric disorders. npg a r t I C l e S excitation and striatal hyperdopaminergia) can converge within a longrange circuit disturbance to trigger abnormal locomotor behavior.
RESULTS

Arp2/3 mutant mice respond to antipsychotics
The Arp2/3 mutant mouse model progressively develops psychomotor disturbances, including locomotor hyperactivity and stereotypical activity 25 . Psychomotor behaviors in rodent models often respond to antipsychotics and are triggered by drugs that induce psychosis in humans 26 . To evaluate the Arp2/3 mutant model, we therefore tested the responses of the mice to antipsychotics. In the open field test, adult mutant mice (120-150 days old) displayed an increased distance traveled (Fig. 1a,b) , enhanced rearing ( Supplementary  Fig. 1a,b ) and stereotypical behaviors (Supplementary Fig. 1c,d) , as compared to their littermate controls. In accord with previous studies 27, 28 , the antipsychotic haloperidol at efficacious doses had slight sedating effects in control mice (Supplementary Fig. 1e-g ). However, in the Arp2/3 mutant mice, the behavioral abnormalities were dramatically reduced by haloperidol in a dose-dependent manner, and they were also significantly blunted by a 0.5 mg/kg dose of the atypical antipsychotic clozapine, which showed almost no sedating effect on wild-type (WT) mice (Fig. 1a,b and Supplementary Fig. 1 ).
Antipsychotics are thought to ameliorate psychomotor symptoms largely by antagonizing effects of DA in the striatum 29 , suggesting that motor disturbances in the Arp2/3 mutant mice may be due to elevated striatal DA (stDA). To test this possibility, we measured DA and its metabolites in the ventral striatum of the mutant mice. High performance liquid chromatography (HPLC) of tissue lysates revealed significantly increased DA and its metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in the Arp2/3 mutant striatum as compared to controls (Fig. 1c) . However, serotonin levels in the ventral striatum were unaltered in the mutant mice. These findings confirm that the motor hyperactivity of the Arp2/3 mutant mice is associated with elevation of stDA.
Loss of Arp2/3 function in the mutant mice is driven by a transgene insertion of Camk2a promoter-driven Cre recombinase, which is expressed predominantly in cortical areas and shows very little expression in striatum 25, 30 (Supplementary Fig. 2a-c) . Consistent with this expression pattern, analyses of Arp2/3 mutant mice did not reveal morphological changes in the medium spiny neurons of the striatum (Fig. 1d,e) . In contrast, the mutant mice had a 56% loss of spines in pyramidal neurons of the frontal cortex (Fig. 1f,g) , which progresses over time, coincident with the appearance of hyperactivity 25 . Because haloperidol normalized hyperactivity in the mutant mice and because this phenotype appears during the period associated with spine loss, we tested whether spine loss was reversed by acute haloperidol treatment. Reduced dendritic spine density in the frontal cortex of the Arp2/3 mutant mice was not rescued by haloperidol treatment (Supplementary Fig. 2d,e) . Thus, the rapid drug effect in the Arp2/3 mutant mice was not due to the morphological restoration of cortical spines, but more likely reflected the drug's antagonism of stDA receptors. These findings led us to explore the origin of the cortical circuitry abnormalities leading to elevated stDA and its consequences for behavior.
The frontal cortex in psychomotor agitation and striatal hyperdopaminergia To investigate a possible link between these observations in the Arp2/3 mutant model, we used a rescue approach to screen cortical areas that might be responsible for the locomotor hyperactivity and stDA. (b) Cumulative distance moved per hour for each condition from a (*P = 0.001 for 0.2 mg/kg of haloperidol group in hour 2; *P = 0.0001 for 0.5 mg/kg of clozapine group in hour 2, 0.1 mg/kg and 0.2 mg/kg of haloperidol groups in hour 3, and 0.5 mg/kg of clozapine group in hour 3; two-way repeatedmeasures ANOVA followed by post hoc tests). (c) HPLC-electrochemical detection analysis of DA, its metabolites DOPAC and HVA, and serotonin (5-HT) from the ventral striatum of Arp2/3 mutant (n = 7) and control mice (n = 6) (*P = 0.023 for DA; *P = 0.017 for DOPAC; *P = 0.049 for HVA; P = 0.893 for 5-HT; N.S., not significant; independent t-tests). (d-g) Golgi stain analysis of dendritic spine density from the ventral striatum (d,e) and frontal cortex (f,g) of Arp2/3 mutant and control mice (n = 3 for each group). Representative images (d,f) and average density (e,g) are shown (*P < 0.001; independent t-test); scale bars: top left, 750 µm; top right, 100 µm; bottom, 5 µm. Data are presented as mean ± s.e.m. npg a r t I C l e S We selectively re-expressed recombinant ArpC3 in Cre-positive knockout (KO) neurons in specific brain regions of the Arp2/3 mutant mice using a Flex-adeno-associated virus (AAV)-mediated regional rescue (FARR) strategy to functionally map behavioral phenotypes (Fig. 2a,b) (the selective expression of our Flex-AAV in Cre-positive cells is shown in Supplementary  Fig. 3a-d) . Bilateral FARR targeting the frontal cortex to coexpress ArpC3 and GFP using the ribosomal skipping 2A sequence (Flex-AAV-ArpC3-2A-GFP) significantly curtailed the locomotor hyperactivity (Fig. 2c,d ), elevated rearing behavior ( Fig. 2e and Supplementary Fig. 4a ) and stereotypical activity ( Fig. 2f and Supplementary Fig. 4b ) of the Arp2/3 mutant mice. In contrast, bilateral expression of GFP (Flex-AAV-GFP) alone did not normalize these phenotypes. This effect was specific to the frontal cortex, as the same FARR strategy in the hippocampus did not rescue the motor hyperactivity of the mutant mice (Supplementary Fig. 5 ).
Sensory-motor gating, as assessed by pre-pulse inhibition (PPI), was previously shown to be disrupted in ArpC3 mutant mice 25 . Testing revealed that the reduced PPI in the mutant mice was not normalized by re-expression of ArpC3 in the frontal cortex ( Supplementary  Fig. 4c ), implying that rescue of Arp2/3 in this region is not sufficient to restore normal PPI. We conclude that the frontal cortex is not the primary site important for sensory-motor gating but that it is critical for the abnormal locomotor behavior seen in the Arp2/3 mutant mice.
We next asked whether the rescue of Arp2/3 function in the frontal cortex normalized the elevated stDA found in the Arp2/3 mutant mice. Microdialysis of the ventral striatum (Fig. 2g) revealed an ~3-fold elevation in extracellular DA in the striatum of the Arp2/3 mutant mice. Notably, DA levels were reduced by the re-expression of ArpC3 in frontal cortex, but not by GFP alone (Fig. 2h) . These npg a r t I C l e S data support the hypothesis that loss of Arp2/3 function in frontal cortical neurons leads to abnormal behaviors through elevated DA in the striatum. We further tested this possibility by unilateral injection of rescue virus into the frontal cortex in Arp2/3 mutant mice, followed by monitoring for circling movement, a phenotype classically associated with imbalance in stDA 31 . Movement tracings from the unilaterally rescued Arp2/3 mutant mice revealed a significant rotation toward the rescued side (Fig. 2i,j) . This effect was exacerbated by the psychostimulant amphetamine, which increases the DA concentration in the striatum, confirming a link between motor activity and altered stDA in the mutant mice (Fig. 2i,j) .
Finally, we specifically disrupted Arp2/3 function in the frontal cortex by infection of AAV-Camk2a-Cre-GFP into the frontal cortical region of Arpc3 f/f mice. Bilaterally infected mice displayed a significant (P < 0.05) increase of locomotor activity compared to that of GFP-infected littermate controls ( Supplementary Fig. 6 and Supplementary Table 1), confirming the significance of this region of cortex in controlling locomotor behaviors. Together the combined data show that Arp2/3 loss in the frontal cortex is responsible for the locomotor symptoms and is associated with elevated extracellular stDA of these mice.
Frontal cortical neurons project to DA neurons of the VTA/SNc How does loss of Arp2/3 function in excitatory neurons of the frontal cortex affect stDA levels and motor behaviors? Most stDA is supplied by release from terminals originating from TH-positive neurons in the ventral tegmental area and substantia nigra pars compacta (VTA/ SNc). Previous studies have suggested that there is a projection from frontal cortical neurons to the VTA/SNc region [32] [33] [34] . To determine whether the relevant cortical neurons of the Arp2/3 model show a npg a r t I C l e S similar projection, we examined the anterograde projections of frontal cortical neurons infected by the Flex-AAV-ArpC3-2A-GFP (Fig. 3a) . GFP-positive axons projected ~1 cm to the VTA/SNc area (Fig. 3b) . High-magnification views confirmed that axons from excitatory neurons in frontal cortex projected ventrally through the striatum and then traversed dorsally toward TH-positive DA neurons in the VTA/SNc (Fig. 3c) . Reconstructed projections from confocal z-series showed contacts between GFP-positive frontal cortical axons and TH-positive neurons in the VTA/SNc (Fig. 3d,e) . These findings suggest that the loss of Arp2/3 in the frontal cortex can directly influence DA-producing VTA/SNc neurons.
To establish the population of frontal cortical neurons that make synaptic contacts in the VTA/SNc and to directly visualize this circuit, we performed retrograde tracing of Cre-dependent GFP expression (Fig. 3f ) . Cre-expressing lentiviruses were coated with rabies virus glycoprotein (lenti-FuGB2-Cre) 35 for retrograde expression of Cre recombinase through infection of presynaptic terminals. We independently tested the retrograde expression of Cre by infection of the VTA/SNc region with lenti-FuGB2-Cre in AI-14 Cre reporter mice. tdTomato expression was readily detected in neurons that project their axons into the VTA/SNc, including medium spiny neurons in the striatum and pyramidal cells in the frontal cortex ( Supplementary  Fig. 7a-c) , confirming the expected retrograde expression of Cre.
Using this strategy, the VTA/SNc of WT mice was infected with lentiFuGB2-Cre and the frontal cortex was infected with AAV-Flex-GFP (Cre reporter). GFP expression in neurons of the frontal cortex marked those neurons that project their axons to neurons of the VTA/SNc and that had been infected by the lenti-FuGB2-Cre virus (Fig. 3g) . Two weeks after the infection, optically cleared 36 300-µm-thick brain sections revealed pyramidal cell bodies of GFP-positive neurons in layers 3 to 5 of the frontal cortex (Fig. 3h) . High-magnification views showed axons from these pyramidal neurons directly projecting to the VTA/ SNc (Fig. 3i and Supplementary Video 1) . Confocal imaging verified that the axonal terminals of the GFP positive axons from the frontal cortex made vesicular glutamate transporter 1 (Vglut1)-positive excitatory synaptic contacts with TH-positive DA neurons in the VTA/SNc (Fig. 3j,k and Supplementary Video 1) . Unilateral injection of lentiFuGB2-Cre virus into the VTA/SNc yielded an ipsilateral expression of Flex-GFP in the frontal cortex, indicating that the cortical-VTA/SNc circuitry of each cortical hemisphere is independent ( Supplementary  Fig. 7d,e) . Together these data confirm that a subpopulation of neurons in layers 3-5 of the frontal cortex provide a direct ipsilateral excitatory input to TH-positive neurons in the VTA/SNc.
Spine pruning leads to abnormal synaptic contacts in the frontal cortex A direct excitatory pathway from the frontal cortex to the VTA/SNc implies that increased excitation of this circuit could lead to increased motor activity associated with elevated stDA. However, our finding of a loss of dendritic spines suggested that these neurons should be less excitable, as a result of reduced glutamatergic input. Therefore, we further examined the ultrastructural morphology of frontal cortical pyramidal neuron synapses in the Arp2/3 mutant mice (Fig. 4a) .
Transmission electron microscopic examination of randomly selected fields confirmed the loss of spines receiving visible synaptic contacts in layers 3-5 from the Arp2/3 mutant mice (control: 32.7 ± 0.8 per 100 µm 2 ; Arp2/3 mutant: 17.2 ± 0.6 per 100 µm 2 ) (Fig. 4b) . Unexpectedly, the proportion of asymmetric synapses formed directly onto dendritic shafts was greatly increased (more than fivefold) in the Arp2/3 mutant mice (control: 2.4% ± 0.5; Arp2/3 mutant: 13.8% ± 3.0) (Fig. 4b,c) . Moreover, the neuropil from Arp2/3 mutant mice contained a substantial fraction of abnormal spines with short wide necks and flattened heads contacted by two spatially separated axon terminals; these aberrant double-axon synapses were never detected in WT mice (control: 0% ± 0; mutant: 12.7% ± 2.0) (Fig. 4b,d) .
In contrast, immunoelectron microscopy analysis of the GABAergic input revealed a slight but significant increase in the density of GABAergic synaptic contacts in the mutant material (control: 12.2 ± 0.5 per 100 µm 2 ; mutant: 14.7 ± 0.5 per 100 µm 2 ; P = 0.0007) in a comparable set of fields from frontal cortex (Supplementary Fig. 8 ). These data demonstrate that the main effect of Arp2/3 loss in cortical neuropil is on excitatory synaptic contacts, which leads to a reduction in the number of normal axonal-spine synapses. Nevertheless, axonal contacts remain, and they either shift directly onto dendritic shafts or form multi-axonal synaptic contacts on the remaining spines.
Spine loss results in enhanced pyramidal neuron excitation Dendritic spines are thought to compartmentalize and filter synaptic input [37] [38] [39] . We hypothesized that, in the absence of normal spine structures, the observed shaft and multi-axonal synapses might contribute to aberrant neuronal excitation. To test the impact of these abnormal synaptic contacts on the excitation of the cortico-VTA/SNc circuit, we selectively disrupted Arp2 (Fig. 5a) . Confocal z-series stacks of GFP-positive neurons followed by three-dimensional reconstruction from each side of the frontal cortex verified that there were no differences in spine densities between control KO neurons or rescued neurons 10 days after infection (DAI) (Fig. 5b,c) . However, at 30 DAI, control KO neurons displayed a 53% loss of spines, compared to rescued neurons from the contralateral side (Fig. 5b,c) . This progressive loss of spines over time agrees with our previous report that spines are gradually lost upon Cre-mediated loss of Arp2/3 function in vivo 25 . This time course provided a framework for analyzing the functional consequences of spine loss over time.
We next performed whole-cell patch-clamp recordings of GFPpositive KO and rescue neurons at each time period (Fig. 5d) . At 10 DAI, when spine density was still normal, there were no differences in either the miniature excitatory postsynaptic current (mEPSC) amplitude or frequency (Fig. 5e-g and Supplementary Fig. 9 ). In contrast, at 30 DAI both mEPSC amplitude and frequency were significantly elevated in the KO neurons, compared to rescue neurons (Fig. 5e-g  and Supplementary Fig. 9 ). These findings show that the progressive loss of spines in the VTA/SNc-projecting cortical neurons is associated with the appearance of a cell-autonomous increase in neuronal excitation. This enhanced excitation may be due to the morphological abnormalities (abnormal shaft and double synapses) that emerge in response to the progressive loss of spines.
Activation of the frontal cortex-to-VTA/SNc circuit induces locomotion The above behavioral, microdialysis and electrophysiological data show that loss of Arp2/3 function triggers abnormal synaptic contacts leading to hyperactivation of a frontal cortex-to-VTA/SNc circuit. This increase in activity might ultimately drive elevated stDA and haloperidol-sensitive locomotion. Accordingly, we hypothesized that selective activation of this circuit would elevate locomotor activity in WT mice, mimicking this phenotype of the Arp2/3 mutant mice. To test this hypothesis, we labeled the cortico-VTA/SNc circuit with channelrhodopsin-2 (ChR2) using a VTA/SNc lenti-FuGB2-Cre and cortical Flex-AAV-ChR2 bilateral viral infection strategy (Fig. 6a) . (Selective expression of Flex-AAV-ChR2-mCherry in Cre-positive cells is shown in Supplementary Fig. 3e-h. ) This enabled the selective activation of the circuit by optogenetic stimulation.
Stimulation of this pathway (473 nm, 10-ms square pulses at 30 Hz) evoked ~2-fold elevation of locomotor activity coincident with the onset of laser stimulation (Fig. 6b-d) . However, the illumination of the same area without ChR2 (opsin-free) did not alter the activity of mice (Fig. 6c,d) , confirming that acute activation stimulates movement. We next tested whether the locomotion evoked by light could be prevented by pretreatment with haloperidol, analogously to the behavioral normalization observed in the Arp2/3 mutant mice. We treated WT animals with either haloperidol (0.2 mg/kg intraperitoneally (i.p.)) or vehicle 20 min before optogenetic stimulation. Haloperidol selectively blunted the stimulated locomotor response, as compared to that in vehicle-treated controls (Fig. 6e,f) . These results demonstrate that the excitation of the frontal cortical neurons that project to the VTA/SNc induces locomotion that is depressed by haloperidol, a DA receptor antagonist.
Frontal cortex-VTA/SNc circuit activation elevates stDA
To further analyze the relationship between excitation of the FC projection to the VTA/SNc and hyperdopaminergia in the striatum, we measured extracellular DA in the striatum during the optogenetic activation in the VTA/SNc (Fig. 6g) . Two weeks after infection of Flex-AAV-ChR2-YFP or Flex-AAV-tdTomato (opsin-free control) npg a r t I C l e S into the frontal cortex and lenti-FuGB-Cre into the VTA/SNc, ChR2-YFP expression was readily detected in frontal cortical pyramidal cell bodies and in their axonal fibers projecting to the VTA/SNc (Fig. 6h) .
(The selective expression of Flex-AAV-ChR2-YFP in Cre-positive cells is shown in Supplementary Fig. 3i-l) . One week after the implantation of the optogenetic and microdialysis probes, we collected extracellular dialysate in the striatum before and after optogenetic stimulation (Fig. 6g) . HPLC analyses revealed that acute optogenetic stimulation of the axons in the VTA/SNc significantly increased DA, DOPAC and HVA in the striatum compared to those in opsin-free controls (Fig. 6i ). These data demonstrate that the FC-VTA/SNc projection is important for regulating DA in the striatum. Together, the results of the present study support a molecular and circuit-based mechanism linking cortical spine pruning to locomotor hyperactivity. Our model proposes that the progressive loss of spines in the frontal cortex caused by Arp2/3 deficiency leads to abnormal synaptic contacts (Supplementary Fig. 10a) , resulting in hyperactivation of pyramidal neurons in the frontal cortex that project to the VTA/SNc (Supplementary Fig. 10b ). Enhanced activation of this circuit (Supplementary Fig. 10c,d ) then produces elevated DA in the striatum (Supplementary Fig. 10e) , which ultimately drives antipsychotic-sensitive locomotor hyperactivity (Supplementary Fig. 10f ).
DISCUSSION
The present study of Arp2/3 mutant mice follows our initial characterization of these mice. That study noted that the progressive course of synaptic and behavioral phenotypes bear similarities to symptoms associated with several psychiatric disorders, especially the cognitive, negative and positive symptoms of schizophrenia 25 . Disorganized behavior, which includes excessive motor activity, is a positive symptom of schizophrenia (Diagnostic and Statistical Manual of Mental Disorders IV-R). Motor hyperactivity and stereotypical behaviors in rodent models are considered to be relevant to the underlying neural circuit abnormalities related to the positive symptoms because they respond well to antipsychotics and are induced by drugs that precipitate psychosis in humans 26 . Models of schizophrenia symptoms in mice have the potential to clarify circuit-level concepts and serve as portals to map the pathophysiology of disorder-associated symptoms. However, schizophrenia is complicated by the observations of heterogeneous pathologies whose relationships to each other (if any) are not understood. These pathologies include excessive pruning (loss) of cortical dendritic spines, excitation of glutamatergic circuitry in the cortex and elevated dopaminergic tone in striatum [40] [41] [42] .
In this study we mapped a functional frontal cortical-VTA/SNc circuit, in which abnormal excitation emerges to drive elevated stDA and motor disturbances. The elevated DA and motor disturbance were mimicked in WT animals by acute optogenetic stimulation of this pathway. The hyperactivity of both the Arp2/3 mutant mice and optogenetically induced mice were normalized by the antipsychotic haloperidol.
Excitatory neurons in the cortical region that make synaptic contact with the VTA/SNc appear to originate from several frontal cortical regions, including the frontal association cortex, anterior secondary motor cortex and prelimbic cortex (Supplementary Fig. 7e ), which overlap with areas considered homologous to the primate prefrontal npg a r t I C l e S cortex (PFC). This long-range circuit may be conserved in humans, and functional magnetic resonance imaging suggests it functions to modulate motivation for reward in healthy individuals 43 . Synaptic refinement and maturation of the PFC continues into late childhood, suggesting that disturbances in this region may correlate to the delayed onset of positive schizophrenia symptoms 44 . Moreover, recent neuroimaging and electroencephalographic studies implicate connectivity disturbances localized to the PFC in schizophrenia 45, 46 , while enhanced activation of pyramidal neurons in this region can recapitulate aspects of the disorder in rodent models 41, 47 .
Our results highlight the surprising finding that loss of spines, previously observed with Golgi analysis and neuroimaging of gray matter density in many neurodevelopmental and degenerative disorders, can lead to increased rather than decreased neuronal excitation. We speculate this is most likely to occur when there is spine loss triggered in postnatal periods, after the formation of synapses, as opposed to impaired spine development, which can also result in reduced spine density.
Together the results of this study identify a new mechanism downstream of an impaired synaptic actin filament pathway that results in a neural circuit abnormality leading to pathological stDA and motor disturbances relevant to several psychiatric disorders. Our findings of abnormal connectivity are the first, to our knowledge, to provide a potential explanation for seemingly unrelated observations in schizophrenia, such as pathological loss of cortical spines, enhanced excitation of cortical excitatory neurons and altered striatal output [40] [41] [42] [48] [49] [50] . These results highlight the need for future strategies to directly target the mechanisms leading to endophenotypes relevant to psychiatric disturbance, rather than current antipsychotic drugs, which appear to ameliorate the downstream consequences of circuit abnormalities.
METHODS
Methods and any associated references are available in the online version of the paper. a r t I C l e S
ONLINE METHODS
Animals. Conditional ArpC3 knockout animals (Arpc3 f/f ) and Camk2a-Cre line (stock number 005359; Jackson Laboratory) have been described previously 25 . The genetic background of mice was 129Sv × C57BL/6J. Male and female littermates from heterozygous pairings were used in all experiments. A Rosa26-lox-stoplox-tdTomato reporter line (generously provided by F. Wang, Duke University, Durham, NC) and AI-14 line (B6;129S6-Gt(ROSA)26Sor tm14(CAG-tdTomato)Hze /J; stock no. 007908; Jackson Laboratory) were used for marking the Cre-positive neurons in the brain. For the optogenetic studies, C57BL/6J mice were purchased from Jackson Laboratory (stock no. 000664). All mice were housed (3-5 mice per cage) in the Duke University's Division of Laboratory Animal Resources facilities (light on at 7:00 a.m., light off at 7:00 p.m.). All tests were conducted during the light cycle. Animal groups were randomly assigned from the animal number and were given treatments such as viruses before testing. All procedures were conducted with a protocol approved by the Duke University Institutional Animal Care and Use Committee in accordance with US National Institutes of Health guidelines.
Viruses. For production of Cre-dependent ArpC3-expressing adeno-associated virus (AAV), the ArpC3-P2A-eGFP sequence was inserted into vector backbone pAAV-EF1α-DIO (generous gift from J. Ting, MIT). AAV9.EF1α.DIO.ArpC3-P2A-eGFP.WPRE (Flex-AAV-ArpC3-2A-GFP), control AAV9.EF1α.DIO. eGFP.WPRE (Flex-AAV-GFP), AAV1.EF1α.DIO.hChR2(H134R).mCherry. WPRE (Addgene 20297), AAV9.EF1α.DIO.hChR2(H134R).eYFP.WPRE (Addgene 20298), AAV9.CAG.Flex.tdTomato.WPRE.bGH (Allen Institute 864), AAV.9.CaMKll.HI.eGFP-Cre.WPRE and AAV.9.hSynapsin.eGFP.RBG viruses were produced by the University of Pennsylvania Vector Core. Lenti-FuGB2-Cre was described in a previous report 51 . In brief, a human synapsin I (SYN1) promoter containing Cre expression vector pseudotyped lentivirus (pLV)-woodchuck post-transcriptional regulatory element (WPRE) with the two helper plasmids ∆8.9 and FuGB2 (a chimeric envelope protein composed of the extracellular and transmembrane domains of rabies virus glycoprotein and the cytoplasmic domain of VSV-G; generously provided by K. Kobayashi, Fukushima Medical University, Japan) 35 were transfected into HEK293T cells using the polyethylenimine method. Viral particles were concentrated by ultracentrifugation (82,750g for 2 h) and resuspended in PBS.
Stereotaxic surgery. For infections of viruses, mice were deeply anesthetized with intraperitoneal (i.p.) injection of ketamine (150 mg/kg)/xylazine (15 mg/kg). A 33-gauge needle was positioned in the frontal cortex (AP: +2.5 mm, ML: +1.0 mm, DV: −0.5 mm to −1.5 mm brain surface, relative to bregma) or into the VTA/SNc (AP: −3.5 mm, ML: +1.0 mm, DV: −4.2 mm brain surface, relative to bregma) using a stereotaxic frame (David Kopf Instruments). Viruses (0.8-1.0 µl) were infused slowly over 10 min into the targets using a microdriver with a 10-µl Hamilton syringe. For rescue experiments, virus was injected into mice at postnatal day (p) 15-20 to rescue Camk2a-Cre-mediated deletion of ArpC3. For optogenetics, virus was injected into 6-to 7-week-old WT mice. 2-3 weeks after viral infection, flat-cut fiber implants (105 µm fiber diameter and 1.25 mm OD ferrule) were lowered into place bilaterally targeting the frontal cortex (AP: +2.5 mm, ML: +1.0 mm, DV: −0.8 mm brain surface, relative to bregma) and secured in place with dental acrylic. microdialysis and HPlc. Adult mice (p120-150) were anesthetized (i.p.) with ketamine and xylazine (80 mg/kg and 8 mg/kg, respectively), and a CMA-7 guide cannula was implanted into the right ventral striatum (AP: +1.3 mm, ML: +1.3 mm, DV: −3.5 mm brain surface, relative to bregma). Five days later a CMA-7 microdialysis probe (Cuprophane, 6 kDa cut-off; 0.24 mm OD; 2 mm membrane length; CMA microdialysis, Kista, Sweden) was inserted into the guide cannula. Probes were perfused with artificial cerebrospinal fluid (aCSF) (in mM: 147 NaCl, 2.7 KCl, 1.2 CaCl 2 and 0.85 MgCl 2 ) at 0.8 µl/min. After 1 h the flow rate was reduced to 0.090 µl/min and the probe further equilibrated for 3 h before collecting the dialysate. Samples were collected into ice-cold tubes filled with 3 µl of a mixture of oxalic acid, acetic acid and l-cysteine (1 mM, 100 mM and 3 mM; respectively). Samples were analyzed by HPLC-EC using an Alexys monoamine analyzer (Antec, Palm Bay, Florida, USA). The analyzer consisted of a DECADE II detector coupled to a VT-03 flow cell (Antec, USA). DA in microdialysis samples was separated on a C18 reverse-phase 1 mm × 50 mm column (3 µm particle size, ALF-105; Antec, USA) at 50 µl/min using a mobile phase (50 mM phosphoric acid, 0.1 mM EDTA, 8 mM KCl, 12% methanol and 500 mg/L 1-octane sulfonic acid sodium salt, pH 6.0) at a potential of 0.3 V. The chromatograms were analyzed using the Clarity software package (DataApex, Prague, Czech Republic); a signal-to-noise ratio of 3 was considered the limit of detection. For simultaneous optogenetic and microdialysis experiments, microdialysis was performed using bilateral cannulation (AP: +1.3 mm, ML: ± 1.3 mm, DV: −3.5 mm brain surface, relative to bregma). Probes were perfused with aCSF (1.2 µl/min) and equilibrated for 1 h before collecting first baseline samples and then laser-stimulated samples. All samples were collected and analyzed as above. To measure levels of DA and its metabolites in tissue, ventral striatum was rapidly dissected, flash frozen in liquid nitrogen, and stored at −80 °C until analysis. DA and its metabolites were measured in a Coulochem III HPLC system with 5014B analytical cell and 5020 guard cell (ESA Inc., Chelmsford, MA, USA). The guard cell potential was set at +0.38 mV and the first and second electrodes of the analytical cell were at −0.15 and +0.35 mV, respectively. All quantifications were conducted in a blinded manner.
Imaging. All representative images were from at least three samples.
golgi-cox staining. Golgi-Cox staining procedures were performed as previously described 25, 52, 53 . Adult mice (p120-150) were deeply anesthetized with isoflurane and then perfused transcardially with Tris-buffered saline (TBS; pH 7.4) containing 25 U/ml heparin, followed by 4% paraformaldehyde (PFA) in TBS. Brains were removed and treated with solutions A and B from the FD Rapid GolgiStain Kit (FD NeuroTechnologies) for 2 weeks and then treated with solution C for 7 d. Sections (100 µm thick) were cut by cryostat and transferred to solution C and incubated for 24 h at 4 °C. After rinsing briefly with distilled water, floating sections were stained with solutions D and E for 30 min and then transferred to a 0.05% gelatin solution. Sections were mounted onto glass slides, dehydrated through a graded series of ethanol concentrations and then mounted with Permount (Fisher Scientifics). z-series images of secondary or tertiary branches of neurons were collected on an AxioCam MRm (Zeiss) on an Axio Imager M1 microscope (Zeiss) under a 63× oil-immersion objective using AxioVision 4.8.2 software (Zeiss). For quantification, spine density was calculated from the z-series images of pyramidal neurons from the frontal cortex (layers 3-5) or striatal medium spiny neurons using ImageJ software (NIH). All quantifications were conducted in a blinded manner. circuit tracing. Mice infected with Flex-AAV-ArpC3-2A-GFP in the frontal cortex at p15-20 were perfused at p120-150 as described above. Brains were removed, post-fixed overnight at 4 °C, and then cryoprotected with 30% sucrose in TBS. Brains were cut into 50 µm sagittal sections by cryostat (Leica CM 3000). Sections were treated with blocking solution (TBS containing 5% normal goat serum and 0.2% Triton X-100) for 2 h and incubated overnight at 4 °C with rabbit anti-tyrosine hydroxylase polyclonal antibody (1:1,000; Calbiochem; catalog number 657012). After washing three times for 10 min per wash with TBST (TBS containing 0.2% Triton X-100), sections were incubated with Alexa Fluor 555-IgG secondary antibody (1:500; Molecular Probes; catalog number A-31572) for 1 h at room temperature. Sections were counterstained with a 4′,6-diamidino-2-phenylindole solution (DAPI; Sigma-Aldrich). After washing four times, the sections were coverslipped with FluorSave (CalBioChem) aqueous mounting medium. Sagittal images were taken by tile scan imaging using LSM 710 confocal microscope (Zeiss).
For the axonal fiber tracing, adult WT mice (2-3 months old) were infected with lenti-FuGB2-Cre (VTA/SNc) and AAV-Flex-GFP (frontal cortex) for 2 weeks. The perfused and cryoprotected brains were cut into 300-µm sagittal sections using a cryostat (Leica CM 3000) and then optically cleared by the SeeDB method as described 36 . Whole sagittal image were taken by tile scan imaging using a LSM 710 confocal microscope (Zeiss) with a 10× objective under control of Zen software (Zeiss). For triple labeling, sagittal brain sections (50 µm thick) were incubated overnight at 4 °C with guinea pig anti-Vglut1 antibody (1:500; Millipore; catalog number AB5905) together with rabbit anti-tyrosine hydroxylase polyclonal antibody (1:1,000; Millipore; catalog number 657012). After washing, sections were incubated with anti-guinea pig Alexa Fluor 647-IgG In the version of this article initially published online, "USA" was included at the end of the two affiliations in Hungary. The error has been corrected for the print, PDF and HTML versions of this article.
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